Duobrii NDC 0187-0653

NDC codes

FDA NDC Directory

Product NDC (as listed)0187-0653Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00187-0653Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0187-0653-01	00187065301	1 TUBE in 1 CARTON (0187-0653-01) / 100 g in 1 TUBEMarketed from Apr 25, 2019
0187-0653-03	00187065303	6 TUBE in 1 CARTON (0187-0653-03) / 3 g in 1 TUBEMarketed from Apr 25, 2019 · Sample package

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Duobrii
Generic name (nonproprietary): halobetasol propionate and tazarotene
Active ingredients: Halobetasol propionate — .1 mg/gTazarotene — .45 mg/g
Dosage form: Lotion
Route: Topical
Labeler: Bausch Health US, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 209354
Marketing start: Apr 25, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)Retinoids (Chemical structure)
Identifiers: Product ID 0187-0653_dbee276a-6a2e-4565-a106-09a5bcca8778SPL ID dbee276a-6a2e-4565-a106-09a5bcca8778SPL set ID b3f0cdc0-69fd-43d1-baf2-d776a3a20715RxCUI 2166089, 2166094UNII 91A0K1TY3Z, 81BDR9Y8PS
Pharmacologic class: Corticosteroid; Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400187065301 followed by a unit qualifier and the quantity

Package 00187-0653-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2020.

Indications (excerpt from the label)

DUOBRII ® (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045% is indicated for the topical treatment of plaque psoriasis in adults. DUOBRII Lotion is a combination of halobetasol propionate and tazarotene indicated for the topical treatment of plaque psoriasis in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)